Clinical trials
Completed Myelodysplastic Syndromes trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 5 |
| Celgene Corporation | 2 |
| Nordic MDS Group | 2 |
| Novartis Pharmaceuticals | 2 |
| Astex Pharmaceuticals, Inc. | 1 |
| Nanexa AB | 1 |
| Traws Pharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 14 |
| Leukemia, Myelomonocytic, Chronic | 5 |
| Anemia | 2 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Cytopenia | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Hematologic Diseases | 1 |
| Leukemia | 1 |
| Leukemia, Myelomonocytic, Juvenile | 1 |
| Thrombocytopenia | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.